GleamWall
中文EN

PTCT PTC THERAPEUTICS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1070081 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-35.1%
TTM net income YoY-114.1%
TTM EPS YoY-115.5%
Revenue 3-yr CAGR13.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin12.8%
Net margin-9.2%
FCF margin0.2%
EBITDA margin18.1%

Returns

ROE—
ROA-3.6%
ROIC (approx.)—
Asset turnover0.39x

Leverage & solvency

Liabilities / assets106.0%
Debt / equity—
Current ratio3.27x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.10x
Accruals ratio-4.0%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.73B$806.78M
R&D expense$455.25M$534.48M
SG&A expense$347.14M$300.91M
Operating income$866.93M-$302.57M
Pretax income$696.62M-$363.12M
Income tax$13.97M$176,000
Net income$682.64M-$363.30M
EBITDA$905.75M-$226.91M
EPS (basic)8.58-4.73
EPS (diluted)7.78-4.73
Weighted avg. shares (diluted)88.31M76.85M
Balance sheet
Cash & equivalents$984.65M$795.32M
Short-term investments$960.72M$359.99M
Receivables$181.62M$158.55M
Inventory$79.65M$23.19M
Current assets$2.27B$1.37B
PP&E, net$55.37M$60.97M
Goodwill$82.34M$82.34M
Intangibles$388.75M$118.79M
Total assets$2.90B$1.71B
Current liabilities$968.43M$580.98M
Short-term debt$286.63M—
Long-term debt—$285.41M
Total debt—$285.41M
Total liabilities$3.10B$2.80B
Shareholders' equity-$205.31M-$1.10B
Net debt—-$509.90M
Shares outstanding81.47M77.70M
Cash flow statement
Operating cash flow$711.20M-$107.69M
Capital expenditure$8.86M$6.50M
Free cash flow$702.34M-$114.19M
Investing cash flow-$861.98M$44.18M
Financing cash flow$331.09M$255.87M
Depreciation & amortization$38.81M$75.66M
Stock-based compensation$74.55M$74.61M

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.